Abstract
Lithium is a simple cation that has been used clinically since 1950 for the treatment of bipolar disorder. However in the last decade numerous studies either using animal models or human trials suggest that this cation may delay progression of neurodegenerative diseases. One of the main challenges facing researchers in the neurosciences is to identify key molecules in neuronal apoptosis. This would facilitate the identification of targets in order to design drugs for the treatment of Alzheimers disease, Parkinsons disease and other neurological disorders. Although enormous effort has been made in the past few years and it has been demonstrated that the mitochondria comprise a key component of the neuronal apoptotic route, it seems that in addition to the mitochondria other intracellular components are implicated in this process. It has been proposed that DNA damage and re-entry into the cell cycle or the activation of different proteases, such as calpain, could constitute a common pathway in the apoptotic process and thus death processes in neurological diseases. The hypothesis about the implication of calpain in neuronal cell death is supported by existing data on neurodegenerative disorders in the brains of patients who show an increase in proteolytic activity of calpain compared with control brains. Indeed, studies performed in neuronal cell preparations suggest that activation of this protease is accompanied by other features such as structural modifications of the cytoskeleton, cleavage of several receptors, activation of kinases, such as cdk5 or GSK3szlig;, etc. Here, we summarize the potential routes involved in neurodegenerative disorders related to calpain activation, mainly those connected with changes in calcium homeostasis machinery, activation of kinase pathways, transcription factors, and the cell cycle.
Keywords: Neurodegeneration, calcium homeostasis, cytoskeleton, kinases, DNA damage, lithium, calpain, signal transduction, neurodegenerative diseases, tau kinases
Current Drug Metabolism
Title: Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium
Volume: 10 Issue: 5
Author(s): Antoni Camins, Natalia Crespo-Biel, Felix Junyent, Ester Verdaguer, Anna M. Canudas and Merce Pallas
Affiliation:
Keywords: Neurodegeneration, calcium homeostasis, cytoskeleton, kinases, DNA damage, lithium, calpain, signal transduction, neurodegenerative diseases, tau kinases
Abstract: Lithium is a simple cation that has been used clinically since 1950 for the treatment of bipolar disorder. However in the last decade numerous studies either using animal models or human trials suggest that this cation may delay progression of neurodegenerative diseases. One of the main challenges facing researchers in the neurosciences is to identify key molecules in neuronal apoptosis. This would facilitate the identification of targets in order to design drugs for the treatment of Alzheimers disease, Parkinsons disease and other neurological disorders. Although enormous effort has been made in the past few years and it has been demonstrated that the mitochondria comprise a key component of the neuronal apoptotic route, it seems that in addition to the mitochondria other intracellular components are implicated in this process. It has been proposed that DNA damage and re-entry into the cell cycle or the activation of different proteases, such as calpain, could constitute a common pathway in the apoptotic process and thus death processes in neurological diseases. The hypothesis about the implication of calpain in neuronal cell death is supported by existing data on neurodegenerative disorders in the brains of patients who show an increase in proteolytic activity of calpain compared with control brains. Indeed, studies performed in neuronal cell preparations suggest that activation of this protease is accompanied by other features such as structural modifications of the cytoskeleton, cleavage of several receptors, activation of kinases, such as cdk5 or GSK3szlig;, etc. Here, we summarize the potential routes involved in neurodegenerative disorders related to calpain activation, mainly those connected with changes in calcium homeostasis machinery, activation of kinase pathways, transcription factors, and the cell cycle.
Export Options
About this article
Cite this article as:
Camins Antoni, Crespo-Biel Natalia, Junyent Felix, Verdaguer Ester, Canudas M. Anna and Pallas Merce, Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium, Current Drug Metabolism 2009; 10 (5) . https://dx.doi.org/10.2174/138920009788898028
DOI https://dx.doi.org/10.2174/138920009788898028 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer’s Disease
Current Alzheimer Research Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism
Current Drug Metabolism Stem Cell Therapy: A Promising Approach in Treatment of COVID-19
Current Stem Cell Research & Therapy Glia: An Important Target for Anti-Inflammatory and Antidepressant Activity
Current Drug Targets Potential Lithium and Fluoride Interactions in Studies of Glycogen Synthase Kinase-3
Current Enzyme Inhibition Pomegranate as a Possible Treatment in Reducing Risk of Developing Wound Healing, Obesity, Neurodegenerative Disorders, and Diabetes Mellitus
Mini-Reviews in Medicinal Chemistry The Chemistry and Pharmacology of Genistein
The Natural Products Journal mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems
Current Drug Targets Transgenic C. elegans as a Model in Alzheimers Research
Current Alzheimer Research Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Blood-Brain Barrier in NeuroAIDS
Current HIV Research CRISPR-Cas Technology: A Role in Transcriptional Recording and Chromatin Remodeling Events
Current Chemical Biology (-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer’s Disease
Current Alzheimer Research Synaptic Dysfunction in Synucleinopathies
CNS & Neurological Disorders - Drug Targets Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Food, Nutrition & Agriculture Pentameric models as alternative molecular targets for the design of new antiaggregant agents
Current Protein & Peptide Science The Molecular Basis of Memantine Action in Alzheimers Disease and Other Neurologic Disorders: Low-affinity, Uncompetitive Antagonism
Current Alzheimer Research Special Issue on Stem Cells: An Introduction from the Guest Editor
Current Neurovascular Research